Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension

被引：7

作者：

Berman, Nathaniel ^{[1
]}

Hostetter, Thomas ^{[1
]}

机构：

[1] Albert Einstein Coll Med, Bronx, NY 10461 USA

来源：

AMERICAN JOURNAL OF KIDNEY DISEASES | 2008年 / 51卷 / 03期

关键词：

D O I：

10.1053/j.ajkd.2007.12.009

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：370 / 372

页数：3

共 11 条

[1]

Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption [J].

Azizi, M ;

Ménard, J ;

Bissery, A ;

Guyenne, TT ;

Bura-Rivière, A ;

Vaidyanathan, S ;

Camisasca, RP .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (12) :3126-3133

[2]

Hormonal and hemodynamic effects of aliskiren and valsartan and their combination in sodium-replete normotensive individuals [J].

Azizi, Michel ;

Menard, Joel ;

Bissery, Alvine ;

Guyene, Than-Tam ;

Bura-Riviere, Alessandra .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 2 (05) :947-955

[3]

BALCRIS GL, 2007, KIDNEY INT, V72, P879

[4]

Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes [J].

Epstein, Murray ;

Williams, Gordon H. ;

Weinberger, Myron ;

Lewin, Andrew ;

Krause, Scott ;

Mukherjee, Robin ;

Patni, Rajiv ;

Beckerman, Bruce .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (05) :940-951

[5]

FRIED LF, VA NEPHRON D STUDY

[6]

Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells [J].

Huang, Y. ;

Noble, N. A. ;

Zhang, J. ;

Xu, C. ;

Border, W. A. .

KIDNEY INTERNATIONAL, 2007, 72 (01) :45-52

[7]

Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis [J].

Jennings, D. L. ;

Kalus, J. S. ;

Coleman, C. I. ;

Manierski, C. ;

Yee, J. .

DIABETIC MEDICINE, 2007, 24 (05) :486-493

[8]

Meta-analysis: Effect of monotherapy and combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease [J].

Kunz, Regina ;

Friedrich, Chris ;

Wolbers, Marcel ;

Mann, Johannes F. E. .

ANNALS OF INTERNAL MEDICINE, 2008, 148 (01) :30-48

[9]

RETRACTED: Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial (Retracted article. See vol. 374, pg. 1226, 2009) [J].

Nakao, N ;

Yoshimura, A ;

Morita, H ;

Takada, M ;

Kayano, T ;

Ideura, T .

LANCET, 2003, 361 (9352) :117-124

[10]

Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial [J].

Oparil, Suzanne ;

Yarows, Steven A. ;

Patel, Samir ;

Fang, Hui ;

Zhang, Jack ;

Satlin, Andrew .

LANCET, 2007, 370 (9583) :221-229

← 1 2 →